Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
about
Prevention and treatment of neurovascular in-stent stenoses: review of the concepts.Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.Recurrent in-stent restenosis in a symptomatic nonatherosclerotic M1 plaque : successful treatment with paclitaxel-eluting balloon dilatation after repeated failure of conventional balloon reangioplasty.Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons.
P2860
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
@en
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
@nl
type
label
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
@en
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
@nl
prefLabel
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
@en
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
@nl
P2093
P1476
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
@en
P2093
Christina Steger
Guenther Laufer
Nikolaos Bonaros
Simone Heiss
William Sterlacci
P304
P356
10.1016/J.EJCTS.2007.09.015
P577
2007-10-17T00:00:00Z